Cervical Cancer Screening
Percentage of women 21-64 years of age who were screened for cervical cancer using either of the following criteria:
- Women age 21-64 who had cervical cytology performed every 3 years.
- Women age 30-64 who had cervical cytology/human papillomavirus (HPV) co-testing performed every 5 years.
Date Reviewed: November 17, 2017
Support
Health Plan
Integrated Delivery System
Measure Info
MIPS 309NQF 0032CMS 309NQF EndorsedCQMC Core Measure
Measure Type:
Process
Measure Steward:
National Committee for Quality Assurance
Clinical Topic Area:
Cancer Screening
Prevention and Wellness
Women's Preventive Services
Care Setting:
Clinician Office/Clinic
Data Source:
Administrative Claims
Electronic Health Records
Paper Medical Records
ACP supports QPP measure 309: "Cervical Cancer Screening" because the current evidence supports screening in women 21-64 years of age and this measure is based on the most recent United States Preventive Services Task Force recommendations on cervical cancer screening.